Elizabetta A Renzoni

25PUBLICATIONS
83CO-AUTHORS
Immunogenetics (incl. genetic immunology)Media studiesExercise physiologyInjury preventionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype.

Ifan Jenkin, Konstantinos Dimopoulos, Steven D Nathan

|Oct 20, 2025
Conspiracy Theories, MDTs and Communication.

Elisabetta A Renzoni

|Mar 12, 2025
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo-Controlled 6-Minute Walk Test Study.

Giuseppina Ciarleglio, Paolo Cameli, David Bennett

|Jan 31, 2025
Protection of Vulnerable Workers: An Imperative for All.

Elisabetta Renzoni, Piersante Sestini

|Jan 03, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis.

Nina R Goldman, Svetlana I Nihtyanova, Claire F Beesley

|Jul 09, 2024
Let's get physical.

Elisabetta Renzoni, Nicole Sl Goh

Pageof 5

Frequent Collaborators

7 joint publications

Athol U Wells

5 joint publications

Carmel J W Stock

4 joint publications

Raphael Borie

4 joint publications

Felix Chua